LoginGet started
Picture of Exact Sciences logo

EXAS — Exact Sciences Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual income statement for Exact Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue8761,4911,7672,0842,500
Cost of Revenue
Gross Profit6601,1371,3081,5101,846
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,1102,2592,6232,6782,704
Operating Profit-234-768-856-594-205
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-406-829-843-633-202
Provision for Income Taxes
Net Income After Taxes-213-824-596-624-204
Net Income Before Extraordinary Items
Net Income-213-824-596-624-204
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-213-824-596-624-204
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1.62-2.77-3.08-3.48-1.17